EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Determination of Tyrosine Kinase Inhibitors as Antineoplastic Agents in Pharmaceutical and Biological Matrices: An Overview of Recent Analytical Techniques

Edoh Nicodème Gabiam iD, Nevin Erk iD, Wiem Bouali iD, Asena Ayşe Genç iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.202501025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Edoh Nicodème Gabiam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Analytical Chemistry, Ankara University, Ankara, Turkey. Hauptthemen laut MEDLINE: Antineoplastic Agents, Protein Kinase Inhibitors, Protein-Tyrosine Kinases. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tyrosine kinase inhibitors (TKIs), widely used in cancer therapy, comprise diverse classes of therapeutic agents such as alkylating agents, antimetabolites, mitotic inhibitors, and targeted therapies. Due to their therapeutic significance and toxic effects, accurate determination of these drugs in pharmaceutical formulations, biological fluids, and environmental matrices is crucial. However, challenges arise from their complex structures and matrix interferences. This review highlights recent advancements in analytical techniques for TKIs, focusing on liquid chromatography, gas chromatography, capillary electrophoresis, spectroscopic methods, and electrochemical methods employed over the last decade. Innovations in sample preparation, including solid‐phase extraction and molecularly imprinted polymers, have led to improved sensitivity and selectivity. Advanced detection systems like mass spectrometry, electrochemical sensors, and fluorescence techniques are emphasized for trace‐level analysis and real‐time monitoring. Key challenges, including green method development, matrix effect minimization, and method robustness, are discussed. To overcome these challenges, future directions should include the use of nanomaterials, microfluidic devices, and machine learning to enhance analytical efficiency. This review provides insights into emerging strategies for precise TKIs, supporting therapeutic monitoring, environmental safety, and analytical advancements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsProtein Kinase InhibitorsProtein-Tyrosine KinasesHumansNeoplasmsTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

analytical techniquesantineoplasticstyrosine kinase inhibitors

Substanzen

Antineoplastic AgentsProtein Kinase InhibitorsProtein-Tyrosine KinasesTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Faculty of Pharmacy, Department of Analytical Chemistry, Ankara University, Ankara, Turkey.
  • The Graduate School of the Health Sciences, Ankara University, Ankara, Turkey.

ORCID-Profile: Edoh Nicodème Gabiam, Nevin Erk, Wiem Bouali, Asena Ayşe Genç

Zitieren

APA

Gabiam, E. N., Erk, N., Bouali, W., & Genç, A. A. (2026). Determination of Tyrosine Kinase Inhibitors as Antineoplastic Agents in Pharmaceutical and Biological Matrices: An Overview of Recent Analytical Techniques. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501025

Vancouver

Gabiam EN, Erk N, Bouali W, Genç AA. Determination of Tyrosine Kinase Inhibitors as Antineoplastic Agents in Pharmaceutical and Biological Matrices: An Overview of Recent Analytical Techniques. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202501025

BibTeX
@article{Gabiam2026,
  author = {Gabiam, Edoh Nicodème and Erk, Nevin and Bouali, Wiem and Genç, Asena Ayşe},
  title = {Determination of Tyrosine Kinase Inhibitors as Antineoplastic Agents in Pharmaceutical and Biological Matrices: An Overview of Recent Analytical Techniques},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.202501025}
}
Kostenlos starten →